K**********r
发帖数: 2640 | | y*****l
发帖数: 5997 | | K**********r
发帖数: 2640 | 3 下午astm要发言。
他家昨天声明要修改以前的账目，这个消息本身不好，但是，回顾了一把他家当时的情
况，那时大概是换了整个management team，而且后来还换了CFO，因此账目有错误是可
能的。最关键的是，医药烂股主要看现金足不足，能不能活下去，最近是否要稀释，而
这种non-cash债务的变化，完全要看庄家怎么利用。医药烂股是虱子多了不咬，债多了
不愁的。。。 | f**********g
发帖数: 2252 | 4 It's at bottom from the chart, anything to cook?
【在 K**********r 的大作中提到】
: 下午astm要发言。
: 他家昨天声明要修改以前的账目，这个消息本身不好，但是，回顾了一把他家当时的情
: 况，那时大概是换了整个management team，而且后来还换了CFO，因此账目有错误是可
: 能的。最关键的是，医药烂股主要看现金足不足，能不能活下去，最近是否要稀释，而
: 这种non-cash债务的变化，完全要看庄家怎么利用。医药烂股是虱子多了不咬，债多了
: 不愁的。。。
| f**********g
发帖数: 2252 | 5 BIO CEO Conference Live Blog: Day 2
By Adam Feuerstein 02/15/11 - 07:00 AM EST
Stock quotes in this article:CLDA, AVII, NEOP, YMI, ZIOP, CTIC, ASTM
http://www.thestreet.com/_yahoo/story/11008155/1/bio-ceo-confer
NEW YORK (TheStreet) -- Small- and midsized biotech companies get a second day in the investor spotlight this week at the 13th annual BIO CEO & Investor Conference.
I'll be continuing my live-blogging from the BIO CEO conference today, presenting news updates and analysis live from the presentation rooms and breakout (Q&A) sessions.
Biotech companies on my coverage list Tuesday include: Spherix(SPEX_), SuperGen(SUPG_), Clinical Data(CLDA_), Cel-Sci(CVM_), Aastrom Biosciences(ASTM_), AVI BioPharma(AVII_) and Neoprobe(NEOP_).
I'll also be reporting on presentations from StemCells(STEM_), YM BioSciences(YMI_), Ziopharm Oncology(ZIOP_), Cell Therapeutics(CTIC_), Icagen(ICGN_) and Telik(TELK_).
The BIO CEO conference is sponsored by BIO, the biotech industry-lobbying group based in Washington, D.C., and typically invites small- and mid-cap biotech companies to present to an audience of institutional investors. Smaller biotech companies, in particular, lack extensive research coverage from investment banks, so this conference is a good way for these companies to get their stories in front of investors.
This BIO CEO confab live blog will be similar to the real-time coverage I provided in January of the J.P. Morgan Healthcare Conference. Expect breaks in between my postings today because I'll be moving around the conference and waiting for companies to present throughout the day.
I'll do my best to give you continuous coverage, but understand that I'm somewhat at the mercy of the AT&T network and my ability to type into my iPhone while weaving through crowds and listening to biotech executives speak.
Your best bet is to check back into the live blog several times throughout the day.
Like my previous live blogs, I want to keep today's coverage interactive, so feel free to ping me with comments and questions. I will publish and respond to as many of your comments and questions as I can. | f**********g
发帖数: 2252 | 6 BIO CEO Conference Live Blog: Day 1
By Adam Feuerstein 02/14/11 - 04:23 PM EST
quotes in this article:EXAS, MDVN, EXEL
http://www.thestreet.com/story/11005968/1/bio-ceo-conference-li
NEW YORK (TheStreet) -- Small and midsized biotech companies get a turn in
the investor spotlight this week as the 13th annual BIO CEO & Investor
Conference kicks off here this morning.
I'll be live-blogging from the BIO CEO conference over the next two days,
presenting news updates and analysis live from the presentation rooms and
breakout (Q&A) sessions. Biotech companies on my coverage list today include
Exact Sciences(EXEL_), Medivation(MDVN_), Exelixis(EXEL), Resverlogix (RVX:
Toronto) and Sangamo BioSciences(SGMO_).
I'll also try to report on presentations from Cleveland BioLabs(CBLI_),
OnoGenex Pharmaceuticals(OGXI_) and Oncolytics Biotech(ONCY_).
The BIO CEO conference is sponsored by BIO, the biotech industry-lobbying
group based in Washington, D.C., and typically invites small- and mid-cap
biotech companies to present to an audience of institutional investors.
Smaller biotech companies, in particular, lack extensive research coverage
from investment banks, so this conference is a good way for these companies
to get their stories in front of investors.
This BIO CEO confab live blog will be similar to the real-time coverage I
provided in January of the J.P. Morgan Healthcare Conference. Expect breaks
in between my postings today since I'll be moving around the conference and
waiting for companies to present throughout the day. I'll do my best to give
you continuous coverage, but understand that I'm somewhat at the mercy of
the AT&T network and my ability to type into my iPhone while weaving through
crowds and listening to biotech executives speak.
Your best bet is to check back into the live blog several times throughout
the day.
Like my previous live blogs, I want to keep today's coverage interactive, so
feel free to ping me with comments and questions. I will publish and
respond to as many of your comments and questions as I can. | f**********g
发帖数: 2252 | 7 Watch list:
EXAS, MDVN, EXEL,CLDA, AVII, NEOP, YMI, ZIOP, CTIC, ASTM
http://finviz.com/screener.ashx?v=341&t=EXAS,MDVN,EXEL,CLDA,AVI
http://finance.yahoo.com/q/cq?s=EXAS,MDVN,EXEL,CLDA,AVII,NEOP,Y | f**********g
发帖数: 2252 | 8 NEOP very bullish.
ASTM EXAS triangle.
Watch these three.
【在 f**********g 的大作中提到】
: Watch list:
: EXAS, MDVN, EXEL,CLDA, AVII, NEOP, YMI, ZIOP, CTIC, ASTM
: http://finviz.com/screener.ashx?v=341&t=EXAS,MDVN,EXEL,CLDA,AVI
: http://finance.yahoo.com/q/cq?s=EXAS,MDVN,EXEL,CLDA,AVII,NEOP,Y
| f**********g
发帖数: 2252 | 9 CLDA very bulllish and up a lot.
【在 f**********g 的大作中提到】
: Watch list:
: EXAS, MDVN, EXEL,CLDA, AVII, NEOP, YMI, ZIOP, CTIC, ASTM
: http://finviz.com/screener.ashx?v=341&t=EXAS,MDVN,EXEL,CLDA,AVI
: http://finance.yahoo.com/q/cq?s=EXAS,MDVN,EXEL,CLDA,AVII,NEOP,Y
| K**********r
发帖数: 2640 | | | | y*****l
发帖数: 5997 | | K**********r
发帖数: 2640 | 12 下午astm要发言。
他家昨天声明要修改以前的账目，这个消息本身不好，但是，回顾了一把他家当时的情
况，那时大概是换了整个management team，而且后来还换了CFO，因此账目有错误是可
能的。最关键的是，医药烂股主要看现金足不足，能不能活下去，最近是否要稀释，而
这种non-cash债务的变化，完全要看庄家怎么利用。医药烂股是虱子多了不咬，债多了
不愁的。。。 | f**********g
发帖数: 2252 | 13 It's at bottom from the chart, anything to cook?
【在 K**********r 的大作中提到】
: 下午astm要发言。
: 他家昨天声明要修改以前的账目，这个消息本身不好，但是，回顾了一把他家当时的情
: 况，那时大概是换了整个management team，而且后来还换了CFO，因此账目有错误是可
: 能的。最关键的是，医药烂股主要看现金足不足，能不能活下去，最近是否要稀释，而
: 这种non-cash债务的变化，完全要看庄家怎么利用。医药烂股是虱子多了不咬，债多了
: 不愁的。。。
| f**********g
发帖数: 2252 | 14 BIO CEO Conference Live Blog: Day 2
By Adam Feuerstein 02/15/11 - 07:00 AM EST
Stock quotes in this article:CLDA, AVII, NEOP, YMI, ZIOP, CTIC, ASTM
http://www.thestreet.com/_yahoo/story/11008155/1/bio-ceo-confer
NEW YORK (TheStreet) -- Small- and midsized biotech companies get a second day in the investor spotlight this week at the 13th annual BIO CEO & Investor Conference.
I'll be continuing my live-blogging from the BIO CEO conference today, presenting news updates and analysis live from the presentation rooms and breakout (Q&A) sessions.
Biotech companies on my coverage list Tuesday include: Spherix(SPEX_), SuperGen(SUPG_), Clinical Data(CLDA_), Cel-Sci(CVM_), Aastrom Biosciences(ASTM_), AVI BioPharma(AVII_) and Neoprobe(NEOP_).
I'll also be reporting on presentations from StemCells(STEM_), YM BioSciences(YMI_), Ziopharm Oncology(ZIOP_), Cell Therapeutics(CTIC_), Icagen(ICGN_) and Telik(TELK_).
The BIO CEO conference is sponsored by BIO, the biotech industry-lobbying group based in Washington, D.C., and typically invites small- and mid-cap biotech companies to present to an audience of institutional investors. Smaller biotech companies, in particular, lack extensive research coverage from investment banks, so this conference is a good way for these companies to get their stories in front of investors.
This BIO CEO confab live blog will be similar to the real-time coverage I provided in January of the J.P. Morgan Healthcare Conference. Expect breaks in between my postings today because I'll be moving around the conference and waiting for companies to present throughout the day.
I'll do my best to give you continuous coverage, but understand that I'm somewhat at the mercy of the AT&T network and my ability to type into my iPhone while weaving through crowds and listening to biotech executives speak.
Your best bet is to check back into the live blog several times throughout the day.
Like my previous live blogs, I want to keep today's coverage interactive, so feel free to ping me with comments and questions. I will publish and respond to as many of your comments and questions as I can.
--Written by Adam Feuerstein in Boston. | f**********g
发帖数: 2252 | 15 BIO CEO Conference Live Blog: Day 1
By Adam Feuerstein 02/14/11 - 04:23 PM EST
quotes in this article:EXAS, MDVN, EXEL
http://www.thestreet.com/story/11005968/1/bio-ceo-conference-li
NEW YORK (TheStreet) -- Small and midsized biotech companies get a turn in
the investor spotlight this week as the 13th annual BIO CEO & Investor
Conference kicks off here this morning.
I'll be live-blogging from the BIO CEO conference over the next two days,
presenting news updates and analysis live from the presentation rooms and
breakout (Q&A) sessions. Biotech companies on my coverage list today include
Exact Sciences(EXEL_), Medivation(MDVN_), Exelixis(EXEL), Resverlogix (RVX:
Toronto) and Sangamo BioSciences(SGMO_).
I'll also try to report on presentations from Cleveland BioLabs(CBLI_),
OnoGenex Pharmaceuticals(OGXI_) and Oncolytics Biotech(ONCY_).
The BIO CEO conference is sponsored by BIO, the biotech industry-lobbying
group based in Washington, D.C., and typically invites small- and mid-cap
biotech companies to present to an audience of institutional investors.
Smaller biotech companies, in particular, lack extensive research coverage
from investment banks, so this conference is a good way for these companies
to get their stories in front of investors.
This BIO CEO confab live blog will be similar to the real-time coverage I
provided in January of the J.P. Morgan Healthcare Conference. Expect breaks
in between my postings today since I'll be moving around the conference and
waiting for companies to present throughout the day. I'll do my best to give
you continuous coverage, but understand that I'm somewhat at the mercy of
the AT&T network and my ability to type into my iPhone while weaving through
crowds and listening to biotech executives speak.
Your best bet is to check back into the live blog several times throughout
the day.
Like my previous live blogs, I want to keep today's coverage interactive, so
feel free to ping me with comments and questions. I will publish and
respond to as many of your comments and questions as I can.
--Written by Adam Feuerstein in Boston. | f**********g
发帖数: 2252 | 16 Watch list:
EXAS, MDVN, EXEL,CLDA, AVII, NEOP, YMI, ZIOP, CTIC, ASTM
http://finviz.com/screener.ashx?v=341&t=EXAS,MDVN,EXEL,CLDA,AVI
http://finance.yahoo.com/q/cq?s=EXAS,MDVN,EXEL,CLDA,AVII,NEOP,Y | f**********g
发帖数: 2252 | 17 NEOP very bullish.
ASTM EXAS triangle.
Watch these three.
【在 f**********g 的大作中提到】
: Watch list:
: EXAS, MDVN, EXEL,CLDA, AVII, NEOP, YMI, ZIOP, CTIC, ASTM
: http://finviz.com/screener.ashx?v=341&t=EXAS,MDVN,EXEL,CLDA,AVI
: http://finance.yahoo.com/q/cq?s=EXAS,MDVN,EXEL,CLDA,AVII,NEOP,Y
| f**********g
发帖数: 2252 | 18 CLDA very bulllish and up a lot.
【在 f**********g 的大作中提到】
: Watch list:
: EXAS, MDVN, EXEL,CLDA, AVII, NEOP, YMI, ZIOP, CTIC, ASTM
: http://finviz.com/screener.ashx?v=341&t=EXAS,MDVN,EXEL,CLDA,AVI
: http://finance.yahoo.com/q/cq?s=EXAS,MDVN,EXEL,CLDA,AVII,NEOP,Y
|
|
